Healthy men test new DMD drug in early safety study
NCT ID NCT07317063
First seen Jan 06, 2026 · Last updated May 19, 2026 · Updated 18 times
Summary
This early-stage trial tested a single dose of a new drug called GRT6019 in 18 healthy men to see if it is safe and how the body processes it. The study also looked at whether food changes how the drug works. No treatment was given for Duchenne muscular dystrophy (DMD); the results will help plan future studies in people with DMD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY (DMD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Biotrial, Inc
Newark, New Jersey, 07103, United States
Conditions
Explore the condition pages connected to this study.